Description
An F-series PG analog in which the C-1 carboxyl group has been modified to an unsubstituted amide; expected to show the typical intraocular effects of latanoprost, but with the much slower hydrolysis pharmacokinetics of the PG N-amides
Formal name: 9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-amide
Synonyms: 17-phenyl trinor PGF2α amide|Bimatoprost amide
Molecular weight: 387.5
CAS: 155205-89-3
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Ophthalmology